UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin's lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: A GELA study on 974 patients

Annals of oncology, 2000-06, Vol.11 (6), p.685-690

2000

Volltextzugriff (PDF)

Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma : Updated results of the prospective study LNH87-2

Journal of clinical oncology, 1997-03, Vol.15 (3), p.1131-1137

1997

Volltextzugriff (PDF)

Intensive Salvage Therapy With High-Dose Chemotherapy for Patients With Advanced Hodgkin’s Disease in Relapse or Failure After Initial Chemotherapy: Results of the Groupe d’Études des Lymphomes de l’Adulte H89 Trial

Journal of clinical oncology, 2002-01, Vol.20 (2), p.467-475

Ferme, C.

2002

Volltextzugriff (PDF)

Tumor necrosis factor alpha release is a major biological event associated with rituximab treatment

The hematology journal : the official journal of the European Haematology Association, 2001, Vol.2 (6), p.378-384

2001

Volltextzugriff (PDF)

Scénarios professionnels. 1

1994

Volltextzugriff (PDF)

Effect of granulocyte colony-stimulating factor administration in elderly patients with aggressive non-Hodgkin's lymphoma treated with a pirarubicin-combination chemotherapy regimen

Annals of oncology, 1996-11, Vol.7 (9), p.966-969

1996

Volltextzugriff (PDF)

Sarcome granulocytaire du pancréas sans autre localisation extra-pancréatique

La Presse médicale (1983), 2002-06, Vol.31 (22), p.1024-1026

2002

Volltextzugriff (PDF)

Late cardiopulmonary toxicity after treatment for Hodgkin's disease

British journal of cancer, 1992-06, Vol.65 (6), p.908-912

1992

Volltextzugriff (PDF)

Comparison of chemotherapy to radiotherapy as consolidation of complete or good partial response after six cycles of chemotherapy for patients with advanced Hodgkin’s disease: results of the Groupe d’études des Lymphomes de l’Adulte H89 trial

Blood, 2000-04, Vol.95 (7), p.2246-2252

2000

Volltextzugriff (PDF)

In the small non-cleaved-cell lymphoma histologic subtype a poor prognostic factor in adult patients ? A case-controlled analysis

Journal of clinical oncology, 1996, Vol.14 (1), p.240-248

1996

Volltextzugriff (PDF)

Hodgkin et shunt mystérieux

La Revue de médecine interne (Paris), 2001-06, Vol.22, p.279s-280s

2001

Volltextzugriff (PDF)

Une LLC qui ne sait pas dire son diagnostic ?

La Revue de médecine interne (Paris), 2001-06, Vol.22, p.270s-271s

2001

Volltextzugriff (PDF)

À vous couper le souffle et les jambes

La Revue de médecine interne (Paris), 2003-06, Vol.24, p.182s-184s

2003

Volltextzugriff (PDF)

Randomized Comparison of ACVBP and m-BACOD in the Treatment of Patients With Low-Risk Aggressive Lymphoma: The LNH87-1 Study

Journal of clinical oncology, 2000-03, Vol.18 (6), p.1309-1315

2000

Volltextzugriff (PDF)

Présentation atypique des hémopathies malignes : penser au frottis sanguin

La revue de medecine interne, 2008-06, Vol.29, p.S136-S136

2008

Volltextzugriff (PDF)

Estimating the impact of rituximab on bcl-2-associated resistance to CHOP using competing risks in elderly patients with diffuse large B-cell lymphoma (DLBCL)

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.7514-7514

2006

Volltextzugriff (PDF)

Safety of Prophylactic Use of Darbepoetin Alfa in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with R-CHOP 14 or R-CHOP21: Preliminary Results of the LNH03-6B Randomized GELA Study

Blood, 2006-11, Vol.108 (11), p.2436-2436

2006

Volltextzugriff (PDF)

Destruction osseuse massive: un signe atypique de lymphome orbitaire

Journal français d'ophtalmologie, 1998, Vol.21 (10), p.769-772

1998

Volltextzugriff (PDF)

Colite collagène associée à un lupus érythémateux disséminé et à un syndrome des anticoagulants circulants

La revue de medecine interne, 1997, Vol.18 (11), p.908-909

1997

Volltextzugriff (PDF)

Que se cache-t-il sous cette grosse rate ?

La Revue de médecine interne (Paris), 1999, Vol.20, p.311s-312s

1999

Volltextzugriff (PDF)

Une scapulalgie à l'odeur de caramel

La Revue de médecine interne (Paris), 1997, Vol.18, p.s340-s341

1997

Volltextzugriff (PDF)

Autologous stem cell transplantation (ASCT) as consolidation therapy for patients with low-intermediate (LI) risk diffuse large B-cell lymphoma (DLBCL) and overexpression of bcl2 protein. Results of the first interim analysis of the GELA trial LNH98-B2

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.6505-6505

2004

Volltextzugriff (PDF)

Autologous stem cell transplantation (ASCT) as consolidation therapy for patients with low-intermediate (LI) risk diffuse large B-cell lymphoma (DLBCL) and overexpression of bcl2 protein. Results of the first interim analysis of the GELA trial LNH98-B2

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.6505-6505

2004

Volltextzugriff (PDF)

Des leucocytes chevelus et fébriles

La Revue de médecine interne (Paris), 1999, Vol.20, p.313s-314s

1999

Volltextzugriff (PDF)

Leucémie à tricholeucocytes et tumeur de Grawitz

La revue de medecine interne, 1995, Vol.16 (4), p.293-294

1995

Volltextzugriff (PDF)

1 – 25 von 167

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(132)
Mit Volltextzugriff
(135)

Publikationsform

Sprache

Französisch
(119)
Englisch
(49)

Erscheinungsjahr

n.n

Thema

Humans
(34)
Life Sciences & Biomedicine
(28)
Science & Technology
(28)
Sciences Biologiques Et Medicales
(24)
Sciences Medicales
(24)
Female
(17)
Life Sciences
(15)
Adult
(13)
Middle Aged
(13)
Biological And Medical Sciences
(11)
Medical Sciences
(11)
Computed Tomography
(9)
Hemopathies
(9)
Aged
(8)
Bioengineering
(7)
Oncology
(7)
Adolescent
(6)
Antineoplastic Agents
(5)
Hematologic And Hematopoietic Diseases
(5)
Hematology
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin's lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: A GELA study on 974 patients

Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma : Updated results of the prospective study LNH87-2

Intensive Salvage Therapy With High-Dose Chemotherapy for Patients With Advanced Hodgkin’s Disease in Relapse or Failure After Initial Chemotherapy: Results of the Groupe d’Études des Lymphomes de l’Adulte H89 Trial

Tumor necrosis factor alpha release is a major biological event associated with rituximab treatment

Scénarios professionnels. 1

Effect of granulocyte colony-stimulating factor administration in elderly patients with aggressive non-Hodgkin's lymphoma treated with a pirarubicin-combination chemotherapy regimen

Sarcome granulocytaire du pancréas sans autre localisation extra-pancréatique

Late cardiopulmonary toxicity after treatment for Hodgkin's disease

Comparison of chemotherapy to radiotherapy as consolidation of complete or good partial response after six cycles of chemotherapy for patients with advanced Hodgkin’s disease: results of the Groupe d’études des Lymphomes de l’Adulte H89 trial

In the small non-cleaved-cell lymphoma histologic subtype a poor prognostic factor in adult patients ? A case-controlled analysis

Hodgkin et shunt mystérieux

Une LLC qui ne sait pas dire son diagnostic ?

À vous couper le souffle et les jambes

Randomized Comparison of ACVBP and m-BACOD in the Treatment of Patients With Low-Risk Aggressive Lymphoma: The LNH87-1 Study

Présentation atypique des hémopathies malignes : penser au frottis sanguin

Estimating the impact of rituximab on bcl-2-associated resistance to CHOP using competing risks in elderly patients with diffuse large B-cell lymphoma (DLBCL)

Safety of Prophylactic Use of Darbepoetin Alfa in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with R-CHOP 14 or R-CHOP21: Preliminary Results of the LNH03-6B Randomized GELA Study

Destruction osseuse massive: un signe atypique de lymphome orbitaire

Colite collagène associée à un lupus érythémateux disséminé et à un syndrome des anticoagulants circulants

Que se cache-t-il sous cette grosse rate ?

Une scapulalgie à l'odeur de caramel

Autologous stem cell transplantation (ASCT) as consolidation therapy for patients with low-intermediate (LI) risk diffuse large B-cell lymphoma (DLBCL) and overexpression of bcl2 protein. Results of the first interim analysis of the GELA trial LNH98-B2

Autologous stem cell transplantation (ASCT) as consolidation therapy for patients with low-intermediate (LI) risk diffuse large B-cell lymphoma (DLBCL) and overexpression of bcl2 protein. Results of the first interim analysis of the GELA trial LNH98-B2

Des leucocytes chevelus et fébriles

Leucémie à tricholeucocytes et tumeur de Grawitz

Aktive Filter

Suchergebnisse filtern